Rhythm Pharmaceuticals (RYTM) had the highest return between June 1, 2022 and October 30, 2022 by a mid-cap US stock, returning 657.8%.
| ASSET | DATE | % RETURN |
|---|---|---|
Rhythm Pharmaceuticals (RYTM) | 6/1/2022 - 10/30/2022 | 657.76% |
Akero Therapeutics (AKRO) | 6/1/2022 - 10/30/2022 | 372.61% |
Nuvalent (NUVL) | 6/1/2022 - 10/30/2022 | 297.08% |
Verona Pharma PLC ADR (VRNA) | 6/1/2022 - 10/30/2022 | 184.33% |
Immunovant (IMVT) | 6/1/2022 - 10/30/2022 | 161.47% |
Impinj (PI) | 6/1/2022 - 10/30/2022 | 143.77% |
Wingstop (WING) | 6/1/2022 - 10/30/2022 | 101.21% |
Catalyst Pharmaceuticals (CPRX) | 6/1/2022 - 10/30/2022 | 95.72% |
Calix (CALX) | 6/1/2022 - 10/30/2022 | 95.35% |
Belite Bio Inc ADR (BLTE) | 6/1/2022 - 10/30/2022 | 89.97% |
New Oriental Education & Technology (EDU) | 6/1/2022 - 10/30/2022 | 89.31% |
Viking Therapeutics (VKTX) | 6/1/2022 - 10/30/2022 | 84.89% |
Arcellx (ACLX) | 6/1/2022 - 10/30/2022 | 84.34% |
Scholar Rock (SRRK) | 6/1/2022 - 10/30/2022 | 83.73% |
Vaxcyte (PCVX) | 6/1/2022 - 10/30/2022 | 80.29% |
Extreme Networks (EXTR) | 6/1/2022 - 10/30/2022 | 78.78% |
Axsome Therapeutics (AXSM) | 6/1/2022 - 10/30/2022 | 67.6% |
TransMedics (TMDX) | 6/1/2022 - 10/30/2022 | 66.53% |
ELF Beauty (ELF) | 6/1/2022 - 10/30/2022 | 64.67% |
Enphase Energy (ENPH) | 6/1/2022 - 10/30/2022 | 62.62% |
Vertex (VERX) | 6/1/2022 - 10/30/2022 | 60.02% |
Genius Sports (GENI) | 6/1/2022 - 10/30/2022 | 60% |
BridgeBio Pharma (BBIO) | 6/1/2022 - 10/30/2022 | 59.74% |
Sarepta Therapeutics (SRPT) | 6/1/2022 - 10/30/2022 | 58.63% |
Medpace (MEDP) | 6/1/2022 - 10/30/2022 | 54.4% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
